Why ProMIS Neurosciences Inc (PMN) Stock Is Rising
As of 2026-08-25, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 25.36%. Featured in our EPS revision report on 2026-07-30.
Why PMN Stock Is Rising
- ·Current-Year Growth: Projected at 77.42%, supporting the forward estimate revision.
News Context
The primary structural driver is the upward revision to ProMIS Neurosciences' next-year EPS growth estimate, now at 25.36%. This upgrade plausibly follows the company's Q2 2026 earnings report and call, which highlighted zero ARIA-E cases and positive corporate developments. The stock's rise has continued beyond the initial revision, supported by momentum from the upcoming 6-month blinded interim data webinar for the PRECISE-AD Phase 1b trial.
Generated 2026-08-25 · news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.36%
- EPS growth this year
- 77.42%
- EPS next quarter (est)
- -$1.27
- Last price
- $15.36
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 25.36% | 77.42% | -$1.27 | $15.36 |
| 2026-08-24 | 25.36% | 77.42% | -$1.27 | $14.80 |
| 2026-08-23 | 25.36% | 77.42% | -$1.27 | $14.51 |
| 2026-08-21 | 25.36% | 77.42% | -$1.27 | $14.51 |
| 2026-08-14 | 28.61% | 77.92% | -$1.39 | $14.73 |
| 2026-08-13 | 27.14% | 76.67% | -$1.38 | $14.79 |
| 2026-08-12 | 27.14% | 76.67% | -$1.38 | $14.50 |
| 2026-08-11 | 27.14% | 76.67% | -$1.38 | $14.97 |
| 2026-08-10 | 27.14% | 76.67% | -$1.38 | $14.72 |
| 2026-08-09 | 27.14% | 76.67% | -$1.38 | $14.71 |
| 2026-08-07 | 27.14% | 76.67% | -$1.38 | $14.71 |
| 2026-08-06 | 27.14% | 76.67% | -$1.38 | $13.33 |
| 2026-08-05 | 27.14% | 76.67% | -$1.38 | $13.48 |
| 2026-08-04 | 27.14% | 76.67% | -$1.38 | $13.57 |
| 2026-08-03 | 27.14% | 76.67% | -$1.38 | $14.14 |
| 2026-08-02 | 27.14% | 76.67% | -$1.38 | $13.72 |
| 2026-07-31 | 27.14% | 76.67% | -$1.38 | $13.72 |
| 2026-07-30 | 27.14% | 76.67% | -$1.38 | $14.92 |
| 2026-07-29 | 27.14% | 76.67% | -$1.38 | $14.06 |
| 2026-07-28 | 27.14% | 76.67% | -$1.38 | $14.52 |
| 2026-07-27 | 27.14% | 76.67% | -$1.38 | $11.72 |
| 2026-07-26 | 26.67% | 76.36% | -$1.41 | $12.20 |
| 2026-07-24 | 26.67% | 76.36% | -$1.41 | $12.20 |
| 2026-07-23 | 26.67% | 76.36% | -$1.41 | $12.61 |
| 2026-07-22 | 26.67% | 76.36% | -$1.41 | $13.99 |
| 2026-07-21 | 26.67% | 76.36% | -$1.41 | $14.49 |
| 2026-07-20 | 26.67% | 76.36% | -$1.41 | $15.07 |
| 2026-07-19 | 26.67% | 76.36% | -$1.41 | $15.19 |
| 2026-07-17 | 26.67% | 76.36% | -$1.41 | $15.19 |
| 2026-07-16 | 26.67% | 76.36% | -$1.41 | $13.30 |
Reports Featuring PMN
Recent News
- ProMIS Neurosciences Inc (PMN) (Q2 2026) Earnings Call Highlights: Zero ARIA-E Cases and ...GuruFocus.com
- ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate HighlightsGlobeNewswire
- ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer's DiseaseGlobeNewswire
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did ProMIS Neurosciences Inc (PMN) stock go up recently?▾
ProMIS Neurosciences Inc (PMN) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-08-21. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is ProMIS Neurosciences Inc's next-year EPS growth estimate?▾
As of 2026-08-25, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 25.36%, based on analyst consensus.
When was the latest EPS estimate revision for PMN?▾
The most recent revision occurred on 2026-08-21, when analysts adjusted the next-year EPS growth estimate from 28.61% to 25.36%.
What sector and industry does ProMIS Neurosciences Inc belong to?▾
ProMIS Neurosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. ProMIS Neurosciences Inc (PMN) appears here because it was detected by our daily top-EPS-revision-performer screen.